Program

The 21st Annual Peptide Therapeutics Symposium was held in a hybrid format on October 20-21, 2026. Registrants were granted access to recorded presentations following the close of the meeting.

Distinguished scholars and leading industry professionals presented the latest trends in cutting-edge peptide science and drug development.

21st Annual Peptide Therapeutics Symposium October 20 – 21, 2026 Scripps Seaside Forum, 8610 Kennel Way, La Jolla, CA 92037
Tuesday, October 20, 2026
8:00 am - 4:00 pm	Registration Check-in The Scripps Seaside Forum Lobby
8:00 am - 8:30 am	Breakfast & Poster Viewing The Scripps Seaside Forum Lobby
8:30 am - 5:00 pm	21st Annual Peptide Therapeutics Symposium Samuel H. Scripps Auditorium
8:30 am - 8:35 am	"Opening Remarks"
8:35 am - 10:05 am	Plenary Lectures
8:35 am - 9:20 am	Jonathan Campbell, Ph.D., Associate Professor of Medicine, Duke University Mechanisms and Physiology of GIP
9:20 am - 10:05 am	Robert P. Doyle Ph.D., Jack and Laura H. Milton '51 Chair in Chemistry, Syracuse University From Stress Cytokine to Drug Target: Developing Peptide Antagonists of the GDF15-GFRAL-RET Axis
10:05 am - 10:35 am	Beverage Break & Poster Viewing The Scripps Seaside Forum Lobby
10:35 am - 12:05 pm	Session I
10:35 am - 11:05 am	L-C Campeau, Ph.D., Associate Vice President, Head of Small Molecule Process R&D, Merck & Co., Inc. The Evolution Peptide Manufacturing: The Story of the Enlicitide Synthesis and Beyond
11:05 am - 11:35 am	Andrew DeMaria, Ph.D. Senior Scientist, Johnson & Johnson Innovative Medicine Breaking Barriers – Redefining Oral Peptide Drug Delivery through Molecular and Formulation Design
11:35 am - 12:05 pm	Mike Hackett, Ph.D., DABT Senior Director of Pharmacology and Toxicology, MBX Biosciences The Precision Endocrine Peptide (PEP) Platform: Optimized Pharmacokinetics to Reduce Dosing Frequency and Improve Tolerability in Endocrine and Metabolic Diseases
12:05 pm - 1:30 pm	Lunch & Poster Viewing The Scripps Seaside Forum Lawn
1:30 pm - 3:00 pm	Session II
1:30 pm - 2:00 pm	David Van Valen, MD, Ph.D. California Institute of Technology
2:00 pm - 2:30 pm	Gaurav Bhardwaj, Ph.D., Associate Professor of Medicinal Chemistry, University of Washington Generative Peptide Design for Diverse Structures and Functions
2:30 pm - 3:00 pm	Ivan Anishchenko, Ph.D. Senior Director of Deep Learning, Vilya Therapeutics Predicting How Chemically Complex Peptides Bind Their Targets
3:00 pm– 3:30 pm	Beverage Break & Poster Viewing The Scripps Seaside Forum Lobby
3:30 pm - 5:00 pm	Session III
3:30 pm - 4:00 pm	Ahmed H. Badran, Ph.D., Associate Professor, Department of Chemistry, The Scripps Research Institute Programmable Biosynthesis of New-to-Nature Molecules
4:00 pm - 4:30 pm	Guy Salama, Ph.D., Univerity of Pittsburgh, School of Medicine Mechanisms of Cardioprotection by Relaxin-2 in a Rat model of Heart Failure with Preserved Ejection Fraction. Role of Glucocorticoid receptors (GR) Activation
4:30 pm - 5:00 pm	Daniele Catalucci, Ph.D., Co-Founder and Cardiovascular Science Advisor, NanoPhoria From Lung to Heart: Inhalable Nano-in-Micro Delivery of a First-in Class Peptide Drives Cardiac Recovery in HFrEF
5:00 pm - 6:30 pm	Opening Reception The Scripps Seaside Forum Lawn
Wednesday, October 22, 2026
8:00 am - 10:00 am	Registration Check-in The Scripps Seaside Forum Lobby
8:00 am - 8:30 am	Breakfast & Poster Viewing The Scripps Seaside Forum Lobby
8:30 am - 1:00 pm	21st Annual Peptide Therapeutics Symposium Samuel H. Scripps Auditorium
8:30 am - 8:35 am	"Welcoming Remarks"
8:35 am - 10:05 am	Plenary Lectures
8:35 am - 9:20 am	Tamer Coskun, MD, Ph.D., Eli Lilly & Company
9:20 am - 10:05 am	Debbie Hay, Ph.D., Professor, School of Pharmacy and Pharmacology, University of Otago Amylin Receptor Biology
10:05 am - 10:35 am	Beverage Break & Poster Viewing The Scripps Seaside Forum Lobby
10:35 am - 12:05 pm	Session IV
10:35 am - 11:05 am	Jonathan Roth, Ph.D. Biotech Consulting, Metabolic Diseases It Still Takes Two to Tango: Amylin-Based Synergies in the Incretin Era
11:05 am - 11:35 am	Denis Roy, Ph.D., Vice President, Nonclinical Safety & Development, SciLucent Bridging Discovery to IND — Navigating the Transition from Peptide Lead Optimization to Nonclinical Toxicology Development
11:35 am - 12:05 pm	Neil Butt, Ph.D., Orbit Discovery
12:05 pm - 12:55 pm	Amylin Panel Moderator: David Parkes, Ph.D., President, DGP Scientific Inc., Debbie Hay, Ph.D., Professor,School of Pharmacy and Pharmacology, University of Otago" Tamer Coskun, MD, Ph.D., Eli Lilly & Company Jonathon Roth Ph.D., Biotech Consulting, Metabolic Diseases
12:55 pm - 1:00 pm	"Closing Remarks"
1:00 pm - 2:00 pm	Networking Lunch The Scripps Seaside Forum Lawn

News

Symposium

October 20-21, 2026

The 21st Annual Peptide
Therapeutics Symposium